Amundi Iveric Bio, Inc. Transaction History

Amundi

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $13,382 - $20,211	510 Added 6.85%	7,950 $312,000
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $12,396 - $16,307	664 Added 9.8%	7,440 $181,000
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $36,841 - $51,181	-2,137 Reduced 23.98%	6,776 $145,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $81,286 - $168,455	8,913 New	8,913 $102,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.